Used primarily as a research chemical in neuroscience and pharmacology, this compound serves as an intermediate in the synthesis of centrally acting agents. It has been investigated for its potential as a monoamine oxidase inhibitor (MAOI), particularly MAO-B, which relates to neuroprotective effects and possible applications in neurodegenerative disorders like Parkinson’s disease. Due to its structural properties, it is also utilized in the development of analogs for studying neurotransmitter regulation. Its cyclopropylamine core allows for selective binding and metabolic stability, making it valuable in drug design for psychiatric and neurological conditions. Limited to laboratory and preclinical studies, it is not approved for therapeutic use.